A BRIEF HISTORY OF MEDICINE MAN TECHNOLOGIES
In late 2012, Andy Williams was introduced to Brett Roper and subsequent discussions revealed the substantial value of creating a new company that could “house” as well as deliver the substantial experience Medicine Man Denver had acquired over the past five years. In April 2014, the business venture incorporated in Nevada as a ‘C’ Corporation under the name of Medicine Man Technologies, Inc. and began generating revenues through sales of consulting and licensing services. Since the business is based in the advisory and consulting space and not in the actual growing and distribution of the product, the company completed it’s public company filing and had it’s first public sale in January 2016.
Medicine Man Technologies offers cannabis consulting, licensing our state-of-the-art cultivation and dispensary operating solutions. We provide the experience and expertise to clients who have the resources necessary to enter the competitive medical and recreational cannabis marketplace.
Through our pre-licensure consulting services, Medicine Man Technologies will support your efforts within a competitive or non-competitive state application process with the goal of helping your team secure a state-issued operating license. Our proven operational experience and state-of-the-art technology has successfully distinguished our clients in this emerging industry.
Our risk-averse cannabis cultivation technology delivers consistent, high quality, high yield production within a clean-room style environment. Through our licensure services we provide standard operating procedures for all phases of commercial and industrial cannabis cultivation, from clone to counter. In addition, we provide hands-on training and development for your personnel both at Medicine Man Denver and your facility once operational.
Our state-of-the art dispensary model ensures patients and consumers have safe and secure access to a variety of medical and/or recreational cannabis products. Through our licensure services we provide standard operating procedures for dispensary facilities, as well as staffing plans, job descriptions and hands-on training for dispensary personnel both at Medicine Man Denver and your facility once operational.
We work closely with industry-leading extraction partners, who provide the necessary licensing service support and formulations to assist clients with their planned deployment of a successful processing facility. This includes; Dixie Elixirs, Medically Correct, CanCore Concepts, and Tree Frog.
Operating in this emerging industry requires experienced partners who can help you avoid costly mistakes. Medicine Man Technologies’ team of professional consultants can help you navigate the process of becoming a successful cannabis operation. If you’re interested in learning more, we would love to hear from you.
Andy Williams – Chairman of the Board
Andy Williams is the Co-Founder and Chairman of the Board of Medicine Man Technologies and CEO of Medicine Man in Colorado. He is veteran of the US Army, and served three years as a Cavalry Scout in the 3rd Infantry Division. He went on to earn a Bachelor of Science degree in Industrial Engineering from the University of Southern Colorado in Pueblo, CO. Andy has worked in a wide range of manufacturing industries as an industrial engineer, and in leadership positions. He is a lifelong entrepreneur. In 2009 the Ogden letter was published stating the Department of Justice would not utilize their resources to prosecute those individuals following state marijuana laws. That was the call to a new opportunity in the marijuana industry for Andy and his brother, Pete Williams. In December of 2009 they launched Medicine Man with the concept of being the Costco of marijuana. Six years later Medicine Man is now a $17 million a year corporation and has branched out to assist start up marijuana companies and grow facilities across the country with their consulting company, Medicine Man Technologies. They are known as industry leaders throughout the United States.
Brett Roper – CEO & Co-Founder
Mr. Roper has an extensive background in business development, having successfully ‘shepherded’ several Form 10 and S1 filings as well as NASDAQ up listing efforts, most recently co-founding Medicine Man Technologies, a unique cannabis business consultant and advisory service provider. Mr. Roper has a substantial amount of RE based experience, managing acquisition, interim holding, and disposition of substantial industrial properties in the 50,000 to 400,000 SF range and is active in providing design insights for cannabis related property deployment. Mr. Roper has been responsible for management of a national marketing program for a regional RE developer having relationships with SIOR, NAI, CORFAC Global, NAIOP, and other real estate organizations across the country. Mr. Roper has served in a number of advisory capacities to other pre-public and public companies including corporate development, strategic initiative refinement, business turnaround, service as an independent board member, and management of investor relations fundamentals. His extraordinary background has allowed him to become a well-rounded ‘quiet advisor’ to many companies as well as investors in the Canna-business space.
Marc Harvill – Sr. Consultant
As a Sr. Consultant, Marc is responsible for following emerging markets, managing new and existing client relationships, and coordinating training efforts for licensees of Medicine Man Technologies. Marc has a background in pharmacy operations both in the manufacturing and retail space, with more than 10 years of experience. He holds a B.A in Marketing and Spanish from PSU and an M.B.A from Washburn University. Prior to joining Medicine Man Technologies, Marc worked for one of the largest privately operated pharmacy technology companies in the country, specifically focused on training and development, hardware and software testing and quality assurance.
Matt Best – Sr. Consultant
As Sr. Consultant, Matt is responsible for following emerging markets, managing new and existing client relationships, and marketing and event management for the company. He holds a B.A. in Communication and Integrated Marketing Communications from the State University of New York, College at Geneseo. Prior to joining MMT in 2015, Matt worked in the Media department at a prominent national advertising agency while overseeing the media planning and buying team and maintaining responsibility for client relationships across local, regional, and national media accounts. He has a strong background in organizational and interpersonal communication, project management, as well as expertise in marketing, business development and client relations. Matt is an avid skier and enjoys time spent within the National Parks.
Carrie Roberts – Sr. Consultant
Carrie Roberts is a Senior Consultant with Medicine Man Technologies. She has a BA in Sociology and Criminal Justice from Colorado State University. As a former Colorado POST Certified law enforcement officer Carrie is currently on the speakers’ bureau for LEAP (Law Enforcement Action Partnership), an international, non-profit, criminal justice reform agency speaking to both policy makers and the public regarding criminal justice and drug policy reform measures. In this capacity, she is able to provide cultivation and dispensary facility tours, educational presentations and actionable intelligence for law enforcement and legislative officials in states where marijuana legalization is unfolding. She helps those government officials understand how legalizing, taxing and regulating marijuana increases public safety, improves the criminal justice system, enhances racial justice, protects young people, safeguards patients, saves resources, bolsters public health, and generates revenue. Carrie is also on the standards creation board for FOCUS (Foundation of Cannabis Unified Standards), an independent, non-profit, third party source for the creation of cannabis standards. In addition to her law enforcement experience, she has over 13 years of entrepreneurial business experience. As a private investigator, she began the nation’s first mystery shopping company focused exclusively on the cannabis industry to help dispensary operators focus on maintaining compliance, setting standards, and delivering superior customer experience. She has a strong business background in strategic consulting and strategy development, as well as expertise in marketing, business development, and customer experience management.
FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty six hundred dollars for Medicine Man Technologies, Inc. current news coverage by the company. FNMG HOLDS NO SHARES OF Medicine Man Technologies, Inc.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.